NCT01380119View on ClinicalTrials.gov

Tuberculosis (TB) Immunotherapy Phase 2 Study

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions
Tuberculosis
Interventions
BIOLOGICAL

V7

experimental arm

OTHER

placebo

placebo pill

Trial Locations (1)

Unknown

Lisichansk TB Dispensary, Lisichansk

All Listed Sponsors
collaborator

National Medical University, Ukraine

OTHER

collaborator

Immunitor USA Inc.

INDUSTRY

lead

Lisichansk Regional Tuberculosis Dispensary

OTHER

NCT01380119 - Tuberculosis (TB) Immunotherapy Phase 2 Study | Biotech Hunter | Biotech Hunter